Pancreatic Cancer Research

Clinical trialObsTerminated

A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer

Non-interventional Observational Post-authorization Study to Assess Clinical and Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Routine Clinical Practice Treating Pancreatic Cancer (TRUST)

NCT02670746↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Stopped earlyDue to slow recruitment study is being terminated. (Enrollment)
Phase
Obs
Status
Terminated
Study type
Observational
Start
1 October 2015
Expected end
28 November 2017
Enrollment
44 participants
Sites
18
Primary outcomes
Overall survival; Adverse Event (AE)
Sponsor
Industry
Results posted
No
Last update
16 September 2019

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 11